Innovation
37 patent families (15 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,098 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 21 |
| 2022 | 19 |
| 2023 | 19 |
| 2024 | 18 |
| 2025 | 18 |
| 2026 | 5 |
Social engagement
Social engagement: 3.2K social following, 10 posts in the last 12 months — top quartile of its industry.
Investor mix
9 investors on record; lead investors include DS, QUAD, Hana Financial Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 22% |
| Private equity | 1 | 11% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 5 | 56% |
Recent activity
28 May 2026
Milestone
regulatory
8 Apr 2026
Partnership
Compass Therapeutics
18 Mar 2026
Event
AACR Annual Meeting